Our accounting and finance teams are ready to provide assistance with legal aspects involved in the donation.
Donors to The Medulloblastoma Initiative will receive legal support from Kalbian Hagerty LLP, an international general practice law firm serving clients around the world with headquarters in Washington D.C.
All funds will go directly to the Children’s National Hospital, a 501(c)(3) non-profit organization exempt from federal income tax under section 501(c)(3) of Title 26 of the United States Code. That means the donation is tax-deductible to the full extent allowed by law.
An External Advisory Board, consisting of three renowned and independent researchers, is in charge of accountability audits. An initial audit has already been performed at the start the project. Additionally, research milestones will be audited every three months. With full transparency, the MB Initiative will provide semiannual reports with the project evolution.
Ian F. Pollack, MD
Chief of pediatric neurosurgery at UPMC Children’s Hospital of Pittsburgh A. Leland Albright Professor of Neurosurgery at the University of Pittsburgh School of Medicine Co-director of the Neurosurgical Oncology Program at the Hillman Cancer Institute.
Scott Pomeroy, MD, PhD
Neurologist-in-Chief, Chairman, Department of Neurology
Bronson Crothers Professor of Neurology, Harvard Medical School.
William A. Weiss, MD, PhD
Evelyn and Mattie Anderson Endowed Chair in Cancer Research, UCSF Professor, Departments of Neurology, Pediatrics, and Neurological Surgery, UCSF Co-Leader, Pediatric Malignancies Program, UCSF Helen Diller Family Comprehensive Cancer Center.
Donors may choose to have their contribution acknowledged.
Of course, the choice for anonymity will be fully respected.
Stand out among the project’s supporters: